Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LY266097 hydrochloride (LY 266097 hydrochloride) 是 5-HT2 的拮抗剂,对人 5-HT2A、5-HT2B 和 5-HT2C 的 pKis 分别为 7.7、9.8 和 7.6,可用于抑郁症研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 363 | 现货 | ||
5 mg | ¥ 1,180 | 现货 | ||
10 mg | ¥ 1,780 | 现货 | ||
25 mg | ¥ 2,770 | 现货 | ||
50 mg | ¥ 4,120 | 现货 | ||
100 mg | ¥ 5,870 | 现货 | ||
500 mg | ¥ 11,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,170 | 现货 |
产品描述 | LY266097 hydrochloride (LY 266097 hydrochloride) is an antagonist of 5-HT2 with pKis of 7.7, 9.8, and 7.6 for human 5-HT2A, 5-HT2B, and 5-HT2C and can be used in studies about depression. |
靶点活性 | 5-HT2A receptor:7.7 (pKi), 5-HT2B receptor:9.8 (pKi), 5-HT2C receptor:7.6 (pKi) |
体内活性 | In vivo electrophysiological recordings of ventral tegmental area (VTA) dopamine (DA) neurons, dorsal raphe nucleus (DRN) 5-HT neurons and pyramidal neurons in the medial prefrontal cortex (mPFC), and the hippocampus were conducted in anaesthetized Sprague-Dawley rats after the administration of 5-HT2B receptor ligands alone or in combination with the SSRI escitalopram. An escitalopram-induced decrease in DA, but not 5-HT firing activity, was rescued by 2-day co-administration of the selective 5-HT2B receptor antagonist LY266097. In the mPFC, 14-day escitalopram administration alone had no effect on pyramidal neuron firing and burst activity, whereas, aripiprazole administered alone or in combination with escitalopram for 14 days increased pyramidal neuron firing and burst activity. Likewise, the administration of LY266097 alone or its addition on the last 3 days of a 14-day escitalopram regimen increased pyramidal neuron firing and burst activity[1]. |
别名 | LY 266097 hydrochloride |
分子量 | 407.33 |
分子式 | C21H24Cl2N2O2 |
CAS No. | 172895-39-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 56.2 mg/mL (138.1 mM), Sonication and heating to 60℃ are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.455 mL | 12.2751 mL | 24.5501 mL | 61.3753 mL |
5 mM | 0.491 mL | 2.455 mL | 4.91 mL | 12.2751 mL | |
10 mM | 0.2455 mL | 1.2275 mL | 2.455 mL | 6.1375 mL | |
20 mM | 0.1228 mL | 0.6138 mL | 1.2275 mL | 3.0688 mL | |
50 mM | 0.0491 mL | 0.2455 mL | 0.491 mL | 1.2275 mL | |
100 mM | 0.0246 mL | 0.1228 mL | 0.2455 mL | 0.6138 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
LY266097 hydrochloride 172895-39-5 GPCR/G Protein Neuroscience 5-HT Receptor LY 266097 Hydrochloride LY-266097 hydrochloride LY 266097 hydrochloride LY-266097 Hydrochloride LY266097 Hydrochloride Inhibitor inhibitor inhibit